Cargando…
Evaluation of Bleeding Rate and Time in Therapeutic Range in Patients Using Warfarin Before and During the COVID-19 Pandemic—Warfarin Treatment in COVID-19
The treatment process of patients using warfarin is expected to be hindered during the COVID-19 pandemic. Therefore we investigated whether the time in therapeutic range (TTR) and bleeding complications were affected during the COVID-19 pandemic. 355 patients using warfarin were included between Mar...
Autores principales: | Emren, Zeynep Yapan, Şenöz, Oktay, Erseçgin, Ahmet, Emren, Sadık Volkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216412/ https://www.ncbi.nlm.nih.gov/pubmed/34142564 http://dx.doi.org/10.1177/10760296211021495 |
Ejemplares similares
-
Platelet‐Lymphocyte ratio is a predictor for the development of no‐reflow phenomenon in patients with ST‐segment elevation myocardial infarction after thrombus aspiration
por: ŞENÖZ, Oktay, et al.
Publicado: (2021) -
Is myocardial bridge more frequently detected on radial access coronary angiography?
por: Şenöz, Oktay, et al.
Publicado: (2021) -
Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease
por: Emren, Zeynep Yapan, et al.
Publicado: (2014) -
The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
por: Kılıç, Salih, et al.
Publicado: (2017) -
The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR
por: Çelik, Ahmet, et al.
Publicado: (2016)